The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Xyzal 0.5 mg/ml oral solution

0.5 milligram(s)/millilitre Oral solution

PCO Manufacturing Ltd.PPA0465/169/002

Main Information

Trade NameXyzal 0.5 mg/ml oral solution
Active SubstancesLevocetirizine dihydrochloride
Strength0.5 milligram(s)/millilitre
Dosage FormOral solution
Licence HolderPCO Manufacturing Ltd.
Licence NumberPPA0465/169/002

Group Information

ATC CodeR06AE Piperazine derivatives
R06AE09 levocetirizine


Licence Issued20/10/2017
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0095-155-019
Interchangeable List DocumentPDF of Interchangeable List
« Back